Equillium (EQ) Change in Acquisitions & Divestments (2019 - 2025)
Equillium (EQ) reported Change in Acquisitions & Divestments of $4.5 million for Q1 2025, little changed year-over-year from $4.5 million in Q1 2024, and down 25.0% on a QoQ basis from $6.0 million in Q4 2024.
Equillium (EQ) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $4.5 million in Q1 2025.
- Quarterly Change in Acquisitions & Divestments changed 0.0% year-over-year to $4.5 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $4.5 million (down 85.71% YoY) and the FY2025 annual result came in at $4.5 million, down 85.71% from the prior year.
- Change in Acquisitions & Divestments slipped to $4.5 million in Q1 2025 per EQ's latest filing, from $6.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $29.0 million in Q2 2021 and bottomed at $2.5 million in Q4 2021.
- The 5-year median for Change in Acquisitions & Divestments is $11.0 million (2023), against an average of $10.6 million.
- The widest annual swing landed in 2022, when Change in Acquisitions & Divestments tumbled 79.94%; it then soared 380.0% in 2023.
- Tracing EQ's Change in Acquisitions & Divestments over 5 years: stood at $2.5 million in 2021, then soared by 179.2% to $7.0 million in 2022, then surged by 71.92% to $12.0 million in 2023, then tumbled by 50.0% to $6.0 million in 2024, then dropped by 25.0% to $4.5 million in 2025.
- Per Business Quant, the three latest EQ Change in Acquisitions & Divestments figures stand at $4.5 million (Q1 2025), $6.0 million (Q4 2024), and $12.0 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Equillium | 279.21 Mn | 218.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 4.50 Mn |
| Mar 31, 2024 | 4.50 Mn |
| Dec 31, 2023 | 12.00 Mn |
| Dec 31, 2023 | 12.00 Mn |
| Sep 30, 2023 | 11.00 Mn |
| Sep 30, 2023 | 11.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Mar 31, 2023 | 12.00 Mn |
| Mar 31, 2023 | 12.00 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 8.75 Mn |
| Jun 30, 2022 | 8.75 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 2.50 Mn |
| Dec 31, 2021 | 2.50 Mn |
| Sep 30, 2021 | 16.50 Mn |
| Sep 30, 2021 | 16.50 Mn |
| Jun 30, 2021 | 28.99 Mn |
| Jun 30, 2021 | 28.99 Mn |
| Mar 31, 2021 | 12.47 Mn |
| Mar 31, 2021 | 12.47 Mn |
| Dec 31, 2020 | 8.19 Mn |
| Dec 31, 2020 | 8.19 Mn |
| Sep 30, 2020 | 5.23 Mn |
| Sep 30, 2020 | 5.23 Mn |
| Jun 30, 2020 | 8.46 Mn |
| Jun 30, 2020 | 8.46 Mn |
| Mar 31, 2020 | 15.25 Mn |
| Mar 31, 2020 | 15.25 Mn |
| Dec 31, 2019 | 13.21 Mn |
| Dec 31, 2019 | 13.21 Mn |
| Sep 30, 2019 | 10.24 Mn |
| Sep 30, 2019 | 10.24 Mn |
| Jun 30, 2019 | 17.50 Mn |
| Jun 30, 2019 | 17.50 Mn |
| Mar 31, 2019 | 11.58 Mn |
| Mar 31, 2019 | 11.58 Mn |